
Trading Update
References to sales growth in the following commentary are based on constant currency and are in comparison to the same period in the prior year, except where stated.
"I'm pleased with how the Group has performed in the second half of our financial year in what continues to be a challenging environment, characterised by consumer caution, geopolitical uncertainty and inflation.
This has also been a busy period strategically, including the decision to close the Vivergo bioethanol plant, the restructuring of our Spanish sugar business, and an agreement for
Retail
Financial highlights
In H2,
Our trading in the
We continue to expect adjusted operating profit margin for the full year to be broadly in line with last year, reflecting
Market highlights
In the
In
Sales in Central and
In the US, sales are expected to grow around 23% in H2, with growth of 21% in Q3 and projected growth of 24% in Q4. Our stores traded well in H2 and our value proposition resonated with customers. We made further progress with our space expansion programme, opening four new stores in H2, including our first store in
Across the Group, we continued to expand and optimise our store portfolio, including 15 new store openings in H2: 4 in the US, 3 in
1 Kantar,
2 Northern European markets include
Grocery
Grocery sales in H2 are expected to be in line with the prior year, reflecting good growth in our international brands, offset by lower sales in
In the
Overall, we expect Grocery adjusted operating profit in H2 to be slightly below our previous expectations, mostly due to one-off restructuring costs.
Ingredients
Ingredients sales are expected to be broadly in line with last year. Our yeast and bakery ingredients business, AB Mauri, continued to have good underlying growth in most markets and benefited from consolidating the speciality yeast and technology business we acquired last year. Overall sales growth was impacted by currency devaluation and an easing of inflation in
Strong adjusted operating profit in Ingredients in H2 is expected to be slightly ahead of our previous expectations.
Sugar
For the full year, we continue to expect the adjusted operating loss for Sugar, including our Vivergo bioethanol plant, to be close to
As expected in H2, sales and profitability in our Sugar businesses in the
In
In 2026, we expect some improvement in Sugar profitability. However, whilst we will benefit from having contracted lower beet prices in
Agriculture
Agriculture sales are expected to increase around 1% in H2. Growth was driven by our speciality feed and additives businesses, while sales of compound feed were broadly flat. We expect Agriculture adjusted operating profit in H2 to be significantly below last year, mainly due to a lower contribution from our joint venture, Frontier, as a result of exceptional weather conditions, and one-off costs.
Full year results
We are scheduled to announce our annual results for the 52 weeks to
For further information please contact:
+44 20 7399 6545
+44 20 7638 9571
An investor and analyst call will be held at 09:00 today, Wednesday
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the